|
|
|
|
|
|
|
|
|
|
medical news
CHICAGO — Immunotherapy approaches are evolving for all types of gynecologic malignancies, including ovarian, cervical, and endometrial cancers, according to a poster discussion at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting.1
In this session, Rebecca S. Kristeleit, BSc, MRCP, PhD, consultant medical oncologist at University College London Cancer Institute, reviewed 3 posters evaluating immunotherapies for the treatment of gynecologic cancers.......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.